The effectiveness of adjuvant radiotherapy after thymoma resection: a systematic review and meta-analysis

胸腺瘤切除术后辅助放疗的疗效:系统评价和荟萃分析

阅读:1

Abstract

INTRODUCTION: Our systematic review and meta-analysis aimed to investigate the impact of postoperative radiotherapy(PORT) on patient outcomes following thymoma resection. METHODS: A comprehensive search of PubMed, EMbase, The Cochrane Library, Web of Science, Wanfang, Wipo, and China Knowledge Network databases was systematically conducted. Relevant literature comparing the therapeutic efficacy and effectiveness of thymectomy and thymectomy+ PORT in patients with thymoma published until August 2024 was gathered. The retrospective studies included in this analysis were evaluated using the Newcastle-Ottawa Scale (NOS), while meta-analysis of the literature was performed using Review Manager 5.4 software. RESULTS: A total of 23 retrospective studies, encompassing 13,742 patients, were included in the analysis. Among them, 6,980 patients belonged to the surgery-only group (3,321 male patients and 3,659 female patients), with an average age of 54.08 years. The surgery + PORT group consisted of 6,762 patients (3,385 male patients and 3,377 female patients) with an average age of 53.76 years. All included studies had a NOS score of ≥7.The meta-analysis results revealed that, in comparison to the surgery group, the surgery + PORT group exhibited higher rates of overall survival at 1 year, 3 years, 5 years, and 10 years. Additionally, the surgery + PORT group demonstrated superior disease-free survival (DFS)rates at 1 year and 5 years as well as disease-specific survival (DSS) rates at 3 years, 5 years, and 10 years. However, no significant differences were observed between the two groups in terms of DFS at 3 years or DSS at 1 year. CONCLUSIONS: Available retrospective evidence indicates an association between PORT and improved survival after thymoma resection, though prospective validation is warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12957-025-04127-z.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。